Overview

Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
0
Participant gender:
All
Summary
To highlight the incidence of adverse reactions of Qingkailing Injection.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
China Academy of Chinese Medical Sciences
Criteria
Inclusion Criteria:

- all the patients treated by Qingkailing Injection in the certain centers(hospitals) in
the next 2 years.

- in accordance with ethics requirements.

Exclusion Criteria:

- none.